These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 6114536

  • 21. [Action of the vagus nerve on the carbonic anhydrase content of human gastric mucosa].
    Banciu T, Berinde L, Puşcaş I, Prodan P, Rocsin M, Paraliov T.
    Stud Cercet Med Interna; 1973; 14(1):41-6. PubMed ID: 4219459
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Maintenance treatment of recurrent duodenal ulceration with pirenzepine.
    Petrillo M, Bianchi Porro G.
    Hepatogastroenterology; 1980 Oct; 27(5):369-71. PubMed ID: 7009360
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Carbonic anhydrase inhibitors: antisecretory and cytoprotective properties.
    Puscas I, Buzás G, Puscas JC, Persa F.
    Acta Physiol Hung; 1989 Oct; 73(2-3):167-77. PubMed ID: 2512764
    [Abstract] [Full Text] [Related]

  • 26. [Acid secretion and serum gastrin during acute and chronic treatment with pirenzepine in duodenal ulcer (author's transl)].
    Scholten T, Fritsch WP, Müller JE, Hanrath R, Strohmeyer G.
    Z Gastroenterol; 1981 Jul; 19(7):323-8. PubMed ID: 6895273
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Pirenzepin versus cimetidine in duodenal ulcer: short-term controlled clinical study].
    Girola M, Balducci A.
    Clin Ter; 1983 Jun 15; 105(5):393-6. PubMed ID: 6688209
    [No Abstract] [Full Text] [Related]

  • 29. Inhibition by pirenzepine of nocturnal gastric acid secretion in duodenal ulcer patients.
    Corinaldesi R, Miglioli M, Daniotti S, Stanghellini V, Borghi E, Barbara L.
    Scand J Gastroenterol; 1981 Jun 15; 16(7):929-31. PubMed ID: 6895676
    [Abstract] [Full Text] [Related]

  • 30. [New concepts of the seasonal evolution of duodenal ulcers].
    Puşcaş I, Veress Tudoran L.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979 Jun 15; 31(5):441-4. PubMed ID: 44568
    [No Abstract] [Full Text] [Related]

  • 31. [Pirenzepin in the treatment of duodenal bulbitis (author's transl)].
    Dítĕ P, Hulek P, Trojanová J, Skaunic V.
    Cas Lek Cesk; 1982 Mar 19; 121(11):347-8. PubMed ID: 6896014
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Mechanism of action of the gastric secretion inhibitor Pirenzepin].
    Hammer R, Koss FW.
    Fortschr Med; 1980 Apr 10; 98(14):(549-54). PubMed ID: 6892811
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Histamine and calcium interaction in the process of gastric acid secretion in humans].
    Puşcaş I.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979 Apr 10; 31(6):549-54. PubMed ID: 44758
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.